Table 1. Examples of cytokines-armed OVs, mechanism of action, and cancer types in clinical trials.
MOA: mechanism of action, OV: oncolytic virus, IL-12: interleukin-12, NK: natural killer cells, HSV: herpes simplex virus, TNBC: triple-negative breast cancer, GM-CSF: granulocyte-macrophage colony-stimulating factor, DCs: dendritic cells, GIT: gastrointestinal, IFN-B: interferon beta, VSV: vesicular stomatitis virus, HCC: hepatocellular cell carcinoma, AML: acute myeloid leukemia.
| Cytokines | MOA | Virus Family | OV variants | Cancer type |
| IL-12 [11] | NK and T cells activation. Antiangiogenic. | HSV | M032 | Glioblastoma, astrocytoma, gliosarcoma |
| ONCR-177 | Solid tumors | |||
| Vaccinia | TBio-6517 | Colorectal cancer, TNBC | ||
| GM-CSF [12] | Activation of DCs | Adenovirus | ONCOS-102 | Melanoma |
| HSV | T-VEC | Melanoma, non-melanoma skin cancer, breast cancer, GIT tumors, ovarian cancer | ||
| Paramyxovirus | MED15395 | Solid tumors. | ||
| Vaccinia | Pexa-vec | Renal cell carcinoma, HCC. | ||
| IFN-B [13] | Promote apoptosis, antiangiogenetic, enhance tumor antigenicity [12] | Vesicular stomatitis virus | VSV-IFNB+ | HCC |
| VSV-hIFNbeta-NIS [14] | T-cell lymphoma, AML, multiple myeloma. |